Novarex Co

Novarex Co Gross Margin

The Gross Margin of Novarex Co (194700.KQ) as of Nov 9, 2026 is 17.34 %. In the previous year, Gross Margin was 14.52 % — a change of 19.40% (higher).

Gross Margin

17.34 %

YoY

19.40%

Last updated:

Gross Margin of Novarex Co is 2025 17.34 % . Gross Margin of Novarex Co was 2024 14.52 % . It decreases by 19.40% higher compared to the previous year.

Novarex Co's gross margin stands at 17.3%, up from 14.9% several years earlier.

The Novarex Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
19.26 KRW
Jan 1, 2019
17.99 KRW
Jan 1, 2020
17.59 KRW
Jan 1, 2021
14.87 KRW
Jan 1, 2022
17.10 KRW
Jan 1, 2023
14.54 KRW
Jan 1, 2024
14.52 KRW
Jan 1, 2025
17.34 KRW
The Novarex Co Gross Margin history
YEARGross MarginYoY
17.34 %+19.40%
14.52 %-0.12%
14.54 %-14.99%
17.10 %+15.04%
14.87 %-15.50%
17.59 %-2.18%
17.99 %-6.60%
19.26 %-8.59%
21.07 %+3.80%
20.30 %-3.65%
21.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novarex Co Stock analysis

What does Novarex Co do? Novarex Co Ltd manufactures and sells dietary supplements including vitamin and mineral products, body fat reduction solutions, eye health aids, joint health products, lactic acid bacteria for skin improvement, coenzyme Q10, wild mango seed extract, and spirulina. The company distributes these products domestically in Korea and internationally. Its primary customers are consumers seeking health functional foods and nutritional supplements. The firm focuses on branded products that target specific health concerns such as body fat, eye health, and joint care. Novarex Co Ltd's revenue streams come from the sale of its diverse supplement portfolio to both domestic and international markets. The company's product range includes individual recognition products designed for specific health benefits, alongside general nutritional supplements. Sales are driven by consumer demand for health-focused functional foods and dietary supplements in the Korean market and overseas. The company's manufacturing and distribution operations support its product lines, which include specialized items like wild mango seed extract and spirulina. These products cater to health-conscious consumers looking for natural solutions for body fat reduction, eye health, and skin conditions. Novarex Co Ltd's business model relies on direct sales of branded supplements to end consumers through domestic and international channels. Novarex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novarex Co stock

Gross Margin of Novarex Co is 17.34 % in 2025.

Gross Margin of Novarex Co changed from 14.52 % to 17.34 %, representing a 19.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Novarex Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Novarex Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Novarex Co

All Key Metrics — Novarex Co